Legal & General Group
ANTH

Legal & General Group’s Anthera Pharmaceuticals, Inc. ANTH Stock Holding History

Legal & General Group’s Portfolio ANTH Stock Details ANTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-1,458
Closed -$5K – 3420
2017
Q1 		$5K Hold
1,458
– – ﹤0.01% 3242
2016
Q4 		$8K Buy
1,458
+773
+113% +$13.4K ﹤0.01% 3260
2016
Q3 		$17K Hold
685
– – ﹤0.01% 2826
2016
Q2 		$17K Hold
685
– – ﹤0.01% 2863
2016
Q1 		$19K Hold
685
– – ﹤0.01% 2681
2015
Q4 		$25K Hold
685
– – ﹤0.01% 2672
2015
Q3 		$33K Buy
+685
New +$47.9K ﹤0.01% 2628

Other funds holding ANTH

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
ECM
Element Capital Management New York $1.05B AUM 5.05% 1-Year Est. Return

Legal & General Group's ANTH Position: Q2 2017 in Review

Legal & General Group sold out of Anthera Pharmaceuticals, Inc. (ANTH) in Q2 2017, closing a stake of 1,458 shares — an estimated $5K sold.

Legal & General Group first reported a position in ANTH in Q3 2015 and held it in 7 quarters. The position peaked at $33K in Q3 2015. 40 funds tracked by Wall St. Rank hold ANTH as of Q2 2017.

  • Legal & General Group reported no remaining Anthera Pharmaceuticals, Inc. position as of Q2 2017 after selling out during the quarter.
  • Legal & General Group sold 1,458 Anthera Pharmaceuticals, Inc. shares in Q2 2017, an estimated $5K.
  • Legal & General Group first reported a position in Anthera Pharmaceuticals, Inc. in Q3 2015 and held it in 7 quarters.
  • Legal & General Group's Anthera Pharmaceuticals, Inc. position peaked at $33K in Q3 2015.
  • 40 funds tracked by Wall St. Rank held Anthera Pharmaceuticals, Inc. as of Q2 2017.

Based on Legal & General Group's 13F filing for Q2 2017, filed 3 Aug 2017.